|Bid||45.27 x 2900|
|Ask||45.30 x 1100|
|Day's range||44.84 - 46.37|
|52-week range||36.65 - 64.50|
|Beta (5Y monthly)||0.89|
|PE ratio (TTM)||11.12|
|Earnings date||25 Jun 2020 - 29 Jun 2020|
|Forward dividend & yield||1.83 (4.14%)|
|Ex-dividend date||19 May 2020|
|1y target est||45.88|
Walgreens Boots Alliance (WBA) closed the most recent trading day at $43.55, moving +0.58% from the previous trading session.
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $42.97, marking a +1.92% move from the previous day.
Warren Buffett isn't going to invest in every good value stock that's available on the markets -- there are just too many of them out there. With a good mix of value, stability, and moat, the three stocks listed below could appeal to investors who want to invest like the Oracle of Omaha. Walgreens Boots Alliance (NASDAQ: WBA) is a household name and the pharmacy retailer provides many day-to-day essentials for customers.
To honor the service and sacrifices of Americans who served in the armed forces, Walgreens is offering a weekend Memorial Day percent discount to all veterans, active duty military personnel and their immediate family members, including the families of those who lost their lives in service to their country.
With a sharply rising need for mental health resources since the onset of the COVID-19 pandemic, Walgreens today announced it has completed its first phase of training in Mental Health First Aid, administered by the National Council for Behavioral Health, for all of the company’s health outcomes pharmacists. The training initiative was first announced last May in conjunction with Mental Health Month in the U.S.
CVS Health (NYSE: CVS) and Walgreens Boots Alliance (NASDAQ: WBA) have both rolled out drive-through COVID-19 testing. Consumers probably won't keep on stocking up and filling prescriptions early as much with states relaxing their stay-at-home restrictions.
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Walgreens...
There is great comfort to be found in regular, reliable dividend payouts, especially in times of economic uncertainty. But finding shares that can pay them isn8230;
The eventual stabilization in the business, a high dividend yield, and strong financial resources more than offset the near-term impact of COVID-19 on this pharmacy business.
The company, which has a health insurance business, a large pharmacy benefit manager and retail pharmacy stores, said it still expects 2020 adjusted profit of $7.04 to $7.17 per share, and its shares rose 2.3% to $62.62. "Sticking with the guidance should be enough for the stock at a time when the company is also dedicating extra resources to manage the COVID-19 pandemic," said Bank of America analyst Michael Cherny.
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $42.02, marking a -1.01% move from the previous day.
Beginning today, most Walgreens stores nationwide will resume standard operating hours. The company continues to evaluate and adjust certain operations and offerings to meet the needs of its customers during the pandemic.
(Bloomberg) -- In mid-March, Pete Massaro felt like he was in over his head. The global coronavirus pandemic was spreading quickly through the U.S., and Massaro, an engineer at Verily, the life sciences unit owned by Alphabet Inc., had suddenly been tasked with heading up the company’s efforts to help speed testing people for Covid-19, the disease caused by the virus. He now had three days to open two drive-through testing sites.It was a tall order. Massaro’s team would have to find suitable locations, staff them, source supplies and figure out how to safely do the tests. Then, adding to the stress, President Donald Trump announced out of the blue that Google, Verily’s sister unit under the Alphabet umbrella, was working on a nationwide system to coordinate testing. While Trump mistook Verily for Google, he also overpromised on the effort behind the fledgling operation, which was to start with only two counties in California. The announcement on March 13 threw Massaro’s team abruptly into the spotlight. After a sleepless weekend, Verily’s project went live on Monday March 16. “This didn’t feel as serious until it became very serious,” said Massaro, who is director of automation at Verily. “It sort of shook us into action.”In the nearly two months since Trump’s announcement, the pressure hasn't let up. Verily, along with local health officials, private clinics and large corporations, have scrambled to quickly open thousands of pop-up testing sites across the country in an effort to fill gaps in the American health-care system. But it’s not clear that this patchwork model of testing sites will ever reach the level of testing necessary, or the right people, to ease up on national social distancing requirements and help businesses safely reopen. As of May 4, Verily had facilitated testing for about 42,000 people. That’s a fraction of the nearly 7 million tests done across the U.S. since early January, according to The COVID Tracking Project. But that isn’t nearly up to the 500,000 tests a day experts say the U.S. will need -- at a minimum. Right now, the country is doing about half of that on the most active days. Testing is still limited to people who are ill or part of high-risk populations such as health care workers and nursing home residents. But it will need to expand to include everyone who comes into contact with a person who is positive.Even for a company like Verily, backed by Alphabet with its immense financial and human resources, getting a testing program up and running is extremely complicated. Verily is, at its core, a technology and research company, not a medical facility. Its initial proposal for Covid-19 testing was to create a website to help screen people with symptoms and send them to one of two Verily sites where they could be tested. On its first day in operation, Verily’s website was overwhelmed with applicants. The company tested just 20 people.Since then, it’s moved toward coordinating testing, rather than conducting its own tests or processing the results. Partnering with drugstore chain Rite Aid Corp. and the California Department of Health, Verily is now involved with 37 locations in nine states. Those sites can each do about 250 tests a day. Verily is also looking at mobile and walk-in testing sites to help serve people who don’t have cars or live far from a permanent site. “By scaling to more states and more individual sites, we aim to not only help individuals who need to be tested for Covid-19 but also play a supportive role in driving evidence-driven policy that will successfully manage this health crisis,” a Verily spokesperson said in an email.The U.S. government is pushing for more testing efforts as it seeks to reopen the economy as soon as possible while hoping to avert a second wave of infection. Last week the White House announced that it’s expanding efforts with Rite Aid, Walmart Inc., CVS Health Corp. and Walgreens Boots Alliance Inc. to open parking-lot testing facilities nationwide. The administration is helping determine the locations and is offering funding assistance. As the U.S. moves toward creating more long-term testing solutions, CVS Chief Medical Officer Troyen Brennan has said the company expects small, nimble testing sites in vans or kiosks will become more common, rather than places like a shuttered casino and college where the company opened its first testing sites. CVS is planning to expand its operations to offer testing at 1,000 locations, including in its store parking lots and drive-through windows, and eventually hopes to process 1.5 million tests a month.“This is the blunt part of the pandemic response where we put up big tents and try to keep people socially isolated,” he said in an interview last month. The next step is moving past the emergency phases and designing a system that works smoothly all over the country, Brennan said.Finding locations for testing sites can be difficult, especially with social distancing efforts enforced.“We got chased out of a lot of spots,” Massaro said. Local officials had seen news footage of huge crowds of potentially sick people queueing up for tests elsewhere and didn’t want that in their community, he said.Getting enough equipment to do the tests is also still a problem.“Every day is a struggle to match the amount of PPE and swabs you need,” Massaro said, referring to personal protective equipment for health care workers. “That’s the way the world is right now, getting those supplies in place has taken a lot of work.”Diagnostic testing is just one part of a multipronged effort to get people back to work, eating in restaurants and going to school. Widespread contact tracing, or tracking the disease as it spreads from person to person, will need to be in place to contain new outbreaks, as will antibody tests that help public health officials judge how much a disease has spread within a community and who might be potentially immune to infection. Disagreements between President Trump and state governments over the best approach suggest it’s unlikely a truly coordinated national effort to stop the disease will come together.Still, the private efforts are pushing forward, ramping up testing as best they can on their own. Verily, for instance, has rapidly diverted company resources toward its own testing efforts, sometimes setting up sites virtually overnight.“Scaling the test sites is absolutely doable,” Massaro said. “There’s a lot of innovation happening.”For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
Walgreens owns about 27% of AmerisourceBergen and is its biggest customer. The two companies have explored various possibilities for combining operations in recent years, including a sale of AmerisourceBergen to Walgreens, on the theory that their drug distribution businesses would be better positioned to withstand competitive price pressures through even bigger scale. The coronavirus pandemic has weighed on Walgreens' retail business since then, however.
Walgreens announced today a new digital enhancement to its recently launched ‘on the spot’ drive-thru shopping experience. Tailor-made for drive-thru shopping, customers and patients can now conveniently order select household essential and health & wellness products online in advance and then pay for and pick up these items at the company’s more than 7,300 participating pharmacy drive-thrus nationwide*.
If you've been tracking Rite Aid (NYSE: RAD) in recent weeks, you may have noticed an alarming trend. While its competitor Walgreens Boots Alliance (NASDAQ: WBA) remained a relatively attractive value stock in April as stocks rebounded out of the worst market plunge since the Great Recession, Rite Aid has been all over the map. The company's revenue plunged significantly in the 2018 fiscal year, and things just haven't been the same since.
Walgreens today announced the company has lowered prices on hundreds of medications available through the company’s Prescription Savings Club, offering savings of up to 80 percent off its cash retail prices. The program is now available to all customers,* including those with Medicare and Medicaid coverage. Reduced prices are available on a wide range of medications used to treat common chronic conditions, such as diabetes, asthma, high blood pressure, hypertension, mental health and more.
(Bloomberg) -- Apple Inc. and Alphabet Inc.’s Google earlier this month unveiled an ambitious plan to jury-rig billions of smartphones into coronavirus-tracking beacons, hoping to help public-health authorities fight the disease and pave the way to end lockdowns that have crippled the global economy.Now, just weeks after the announcement, the program is already facing serious challenges and it’s unclear whether the system will ever be used at a large scale. Persistent concerns about privacy, weak consumer adoption, and the lack of a coordinated government effort on testing could all pose obstacles to the companies’ push. Some governments have already struck out on their own, building systems used by millions without needing Apple and Google’s help.The tech giants’ plan involves updating the software on billions of phones so consumers can use wireless technology to track who they come into contact with. If a person notifies the system that they have Covid-19, people who have been near them -- based on their device’s proximity to others -- would get an alert saying they may be at risk. The plan removes technical problems around interoperability and battery life that were plaguing efforts to build such apps before.It’s one of the most ambitious approaches yet to what’s known as digital contact tracing, a way of using technology to supplement existing systems, which involve health workers manually tracking the disease’s spread. Doctors and other health professionals say that a robust system for keeping tabs on exposure to infected individuals is essential to prevent a resurgence of the pandemic.On Wednesday, the two companies launched updates that will let select developers begin building apps using the tools. A second phase of the project, to be released in the coming months, will have deeper integration with Apple’s iOS and Google’s Android operating systems to rely less on apps.The partnership is unprecedented. Apple and Google are bitter business rivals, and have fought for years to outmaneuver each other in the industries they compete directly in, such as phones and internet browsers, as well as in areas that will unlock the technology of the future, like artificial intelligence. Together, the companies’ phones are used by about a third of the world’s population.In addition to coming together on this project, both companies have donated money and put resources toward other coronavirus-combating initiatives. But the problem may be too big even for the vaunted leaders of the tech industry to conquer.“App-based contact tracing is something that has never worked,” said Ross Anderson, a professor of security engineering at the University of Cambridge computer science department in the U.K. “It’s a straw that some people are grasping at out of do-something-itis.”Anderson likens the rush to work on contact tracing as similar to other hype-induced tech trends, like artificial intelligence or Bitcoin. It’s worth pointing out that Apple and Google have been eyeing the health-care industry for years, slowly experimenting with ways to push deeper into the lucrative field. Often, they’ve been met with skepticism and questions about privacy safeguards. Winning goodwill with coronavirus projects could help the companies sell health software or devices down the road.But even if you take a less cynical view, there’s only so much Apple and Google can do to help solve the problem. Contact tracing can only ever be part of a broader system that demands intensive and regular testing, something the U.S. so far hasn’t been able to accomplish.Testing for Covid-19 needs to become much more accessible so people can know whether they have contracted the disease before they can consider telling an app they’ve got the virus. Even if the Apple-Google system preserves privacy, works accurately and is adopted by enough people, it has to be combined with frequent and widespread testing, as well as expensive manual contact tracing, said Daniel Kahn Gillmor, a senior staff technologist at the American Civil Liberties Union, who focuses on privacy and technology.And many countries are far behind on testing. In the U.S., testing ramped up from essentially zero at the beginning of March to 150,000 a day in the first week of April, but it’s since plateaued at around 200,000. Earlier this week, drug retailers such as CVS Health Corp., Walgreens Boots Alliance Inc. and Walmart Inc. said they would ramp up testing in store parking lots, potentially adding millions of new tests a month. Still, these testing operations are at an early stage, and so far have been confusing to patients and other customers.Experts say at least 500,000 tests will need to be done every day to make it safe to allow people to return to work and get the economy moving again. Some say the number is even higher, in the millions.Testing efforts are still beset by supply shortages and coordination issues, and governors including New York’s Andrew Cuomo have accused the federal government of dragging its feet. (Michael Bloomberg, owner of Bloomberg LP, is leading a push in New York, New Jersey and Connecticut to expand testing and contact tracing.)The potential of contact-tracing apps has been overestimated in an atmosphere where people are desperate for solutions, a trio of tech, legal and disease experts wrote in an article for the Brookings Institution think tank on Monday.“We have serious doubts that voluntary, anonymous contact tracing through smartphone apps -- as Apple, Google, and faculty at a number of academic institutions all propose -- can free Americans of the terrible choice between staying home or risking exposure,” the researchers said.Another hurdle is trust -- convincing people that their data won’t be hacked or used for other purposes if they opt into the system. Google, Apple and the other tech giants have faced intense scrutiny in recent years over how they use the data they collect. Health data is especially sensitive, given how personal it is.Apple and Google have gone to great lengths to stress that their proposed contact-tracing technology, which last week they dubbed Exposure Notification, is secure. Privacy experts generally support the method, which uses constantly-changing ID codes and stores information on each individual’s phone instead of a centralized cloud that could be hacked. Still, many consumers are wary of sharing information with tech companies after high-profile data breaches in the last several years. In an update to their original announcement, the companies said they’d made the system even more secure, encrypting the Bluetooth signals that emanate from each person’s phone.But some governments are saying Apple and Google’s plan is too private to be useful. The U.K., which initially said it would work with “the world’s leading tech companies” to build a contact-tracing app, has now rejected Apple and Google. Storing the information centrally helps health authorities track the virus’ spread and move proactively to contain it. The tech giants’ system doesn’t allow for centralization, and only serves to tell individual people whether they’ve come into contact with someone who has the disease. That’s not as useful for officials who want a big-picture idea of what’s happening with the pandemic.Beyond the British system, there are a variety of other apps being deployed without Apple and Google’s help. The French government wants to launch its own app in early May, and is asking Apple to remove a privacy restriction that would hamper the government’s ability to pull Bluetooth data to its own server.In Australia, more than 2 million people have downloaded the country’s app for tracking, according to the country’s government. That’s still short of the 40% of Australia’s 26 million citizens who will need to use it for it to be effective. India’s government said 50 million people were using its own app just 13 days after launch.Regardless of who’s building the app, getting enough people to participate is a challenge of its own. In Singapore, where a similar local system was in place before Apple and Google announced theirs, too few people downloaded the app to make it effective, and the city-state had to impose a lockdown instead.A month after Singapore’s app went live, only about a fifth of the country had downloaded it. On April 21, the country’s prime minister urged citizens to get with the program. “There will be some privacy concerns, but we will have to weigh these against the benefits,” he said in a televised address. If Singapore -- where residents’ technology usage is among the highest in the world and citizens are accustomed to directives from the government -- can’t ensure participation, it’s hard to imagine widespread usage happening in the U.S.Making the app mandatory could solve the adoption problem and ensure a large enough network of users to have a meaningful impact, but doing so might foment resistance or undermine trust in the system itself. In order for people to use it, it has to be voluntary, said the ACLU’s Gillmor.“The moment the systems appear to be punitive or enforced on people, people will move away from them,” Gillmor said.Though most Americans seem to be following government guidelines on the virus so far, some are already bristling at the restrictions on movement and rules about wearing masks in public. Small protests have cropped up across the country and conservative media outlets and some politicians have demanded that governments “open up” their economies immediately.Even a compulsory system that used information from contact tracing to give certain people -- those who already had the virus, for example, or those whom the app showed hadn’t been in contact with anyone positive -- more freedom to move around while limiting others would also be unfair, because it would be biased toward people with access to phones with a working Bluetooth signal. Those who couldn’t participate might be left behind completely, Gillmor said.“If the system is mandatory, that’s going to potentially lock people out who are already fundamentally disadvantaged and already more at risk for Covid-19,” he said.There are also questions about whether Bluetooth, the wireless technology that picks up on other phones that come nearby, is accurate enough to ensure meaningful measurements. If there are too many false positives and people are warned to self-quarantine repeatedly but never develop symptoms, they may begin to believe the system isn’t working.The technological issues, at the least, can be addressed, said Micha Benoliel, co-founder of Nodle, a wireless-tech startup that has developed a contact-tracing app used in the city of Berkeley, California, and run by a nonprofit. Bluetooth is very accurate within distances of 6 feet, Benoliel said, which is exactly the range such an app would want for this purpose.“The world is changing -- it will never be like it used to be,” Benoliel said. “If we want to have something close to a normal life, we need to have this kind of tool.”For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
(Bloomberg Opinion) -- Amazon.com Inc. has come under pressure in a locked-down Europe for doing what it does best: selling consumers everything they need.An appeals court in France on Friday said the U.S. online retailing giant must limit its range to essential items: food, health products and computer equipment. In Germany, competition authorities are monitoring the company after complaints from retailers. It has endured strikes over working conditions in Italy. The grievances differ in each country, and Amazon is contesting them. But the crisis has also cast the defects of its brick-and-mortar competitors into sharp relief. Amazon appears to be dominating partly because of years of missteps from its rivals on Main Street, as well as the company’s sheer brazenness. Where traditional retailers have been cautious about putting staff at risk or appearing insensitive to the health-care crisis, Amazon has carried on filling orders as best as it can.Some online-savvy competitors have also done well. But no one has matched the e-commerce behemoth’s ability to supply homebound consumers with a similarly wide selection and dependable service. And in this unsettling time, everyone’s definition of an urgent essential item is slightly different, spanning books and extension cords to electric toothbrushes and Pilates mats.Other retailers erred on the side of caution when it came to the various national patchworks of lockdown rules.For example, government guidance in the U.K. about which retailers should shut their physical doors was inconsistent. While bicycle shops could stay open, those selling electronics were forced to close. Even in sectors allowed to keep operating, some retailers, such as Kingfisher Plc’s home-improvement chain B&Q, closed shops to protect employees and customers. (It has since reopened 215 stores.) Online, retailers in Britain also faced fits and starts. Some temporarily limited their ranges to handle panic buying. Drugstore operator Boots, owned by U.S. giant Walgreens Boots Alliance Inc., did so to meet the frenzy for paracetamol and hand sanitizer.While understandable in many cases, and admirable in some, every instance where a company shut its doors or restricted available merchandise simply handed another advantage to Amazon.The picture is slightly different in the U.S., where a wider range of retailers has kept trading. Not only were Walmart Inc. and Target Corp. able to continue selling general merchandise alongside food, they also benefited from their investments in e-commerce. Target said last week that its digital sales in April had risen by more than 275%.Even as others have benefited from the heightened demand, Amazon has some massive supply chain advantages. It’s not just the dominance of the company’s 175 fulfillment centers with their combined 150 million square feet of space dotted around the world. It’s also the efficiency with which that space and its contents are managed: Amazon relies heavily on automation both to whizz products around its warehouses, and to order the stock for them. In the book “Always Day One,” the journalist Alex Kantrowitz explained how Amazon uses its 25 years of data on customer orders to predict demand in any particular zip code.Traditionally, a so-called “vendor manager” would work with a brand to decide how much of a given product — Kantrowitz uses the example of Tide detergent — to stock at a given warehouse. Back in 2012, Amazon started developing an automated solution to determine what products were needed, the quantity, and the price. That resulted in a system it dubbed “Hands off the Wheel,” where humans play a far more limited role in managing stock; each vendor manager is now responsible for tens of thousands products, compared with several hundred a few years back.A system like that comes into its own during the current crisis — ensuring that warehouses are replete with the products they’re most likely to need. It might also explain the company’s decision to extend the temporary closing of its warehouses in France in response to the court’s ruling: Unpicking its vastly complex automated stocking operations to focus on a few discrete products is surely incredibly difficult, though not impossible. For competitors, replicating the Amazon approach is a tricky task, particularly in a condensed time frame. And retailers’ caution over how to handle the virus was understandable. Reputations will be won or lost on how companies behaved during the crisis.While criticism of Amazon’s working practices has popped up around the world, it continues to hoover up customer dollars. Call it the Ryanair effect. The airline last year came dead last in Which? magazine’s annual customer satisfaction survey for the sixth time in a row. Yet its 10 billion-euro ($10.8 billion) market capitalization still makes it bigger than Deutsche Lufthansa AG and British Airways parent International Consolidated Airlines Group combined. Amazon’s business too seems immune to criticism, though it doesn’t have Ryanair’s customer satisfaction issues.Its popularity should endure when the world returns to some semblance of normality. For a variety of reasons — avoidance of crowds, for one — many of the sales made online during the pandemic won’t return to brick-and-mortar stores even when they open back up. This year’s jump in U.S. online retail sales, including groceries, to about 17.2% of overall sales, from 13.9% in 2019, will effectively condense two years’ growth into one, according to GlobalData. In the U.K., the proportion of online sales reached a record 22.3% in March, according to the Office for National Statistics.Amazon’s performance during the pandemic means it will be in pole position to capture the extra spending via a click of a mouse or tap of a smartphone. Speed and ease make up for a lot of sins.This column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Alex Webb is a Bloomberg Opinion columnist covering Europe's technology, media and communications industries. He previously covered Apple and other technology companies for Bloomberg News in San Francisco.Andrea Felsted is a Bloomberg Opinion columnist covering the consumer and retail industries. She previously worked at the Financial Times.For more articles like this, please visit us at bloomberg.com/opinionSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
Walgreens today announced plans to open COVID-19 testing locations in 49 U.S. states and Puerto Rico, as the company further expands drive-thru testing to help meet the growing need in communities nationwide. With this latest expansion, Walgreens will focus its efforts on improving access to testing in underserved communities, and over time will also be working with companies to provide testing to employees, to help more businesses re-open in the weeks and months ahead.
Red Nose Day is back at Walgreens for its sixth year, and while the mission to raise money to end child poverty remains more important now than ever, the iconic Red Nose is showing up slightly different. This year, together with Red Nose Day, Walgreens is excited to present the first-ever iconic Red Nose digitally –allowing the spirit of Red Nose Day to unite people to spread joy virtually and raise awareness of the cause, even while staying home and remaining physically distant.
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that its board of directors has declared a quarterly dividend of 45.75 cents per share, unchanged from the previous quarter and an increase of 4 percent from the year-ago quarter. The dividend is payable June 12, 2020, to stockholders of record as of May 20, 2020.
In appreciation and recognition of all medical personnel, first responders and police, and the critical role they’re playing throughout the COVID-19 pandemic, Walgreens is designating April 25 as ‘Frontline Heroes Discount Day,’ providing 30 percent off regularly-priced Walgreens brands and 20 percent off regularly priced national brand products. The frontline heroes can present their employment badge or appropriate identification at any of the more than 9,200 Walgreens stores to receive the discount. Restrictions may apply including current quantity limits on certain high demand products.